Adcytherix
Drug DiscoveryWebsite
Developer of an antibody-drug conjugate platform designed to address resistance and improve safety in cancer therapy through novel payload innovation. The company offers new classes of payload mechani...
Valuation
$0
Share Price
N/A
Total Raised
$160.9M
Last Round
Early Stage VC (Series A)
Jul 2025
Latest Funding Round
Early Stage VC (Series A)
Jul 31, 2025
$126.3M
raised
Investors
+13 other investors